Coverart for item
The Resource Big pharma and drug pricing, Pete Schauer, book editor

Big pharma and drug pricing, Pete Schauer, book editor

Label
Big pharma and drug pricing
Title
Big pharma and drug pricing
Statement of responsibility
Pete Schauer, book editor
Contributor
Editor
Subject
Language
eng
Summary
Americans pay among the highest prices for prescription drugs, thanks to government legislation and the powerful pharmaceutical lobbies. The effect has been disastrous, with many citizens obtaining cheaper medicine from Canada, and others forgoing it altogether at the risk of their health. These crippling prices are set by "big pharma," at the insistence of those who support free trade. Consumers call the pharmaceutical companies greedy and selfish, but these companies also enact change, through scientific research, curing of diseases, and community outreach. What is the answer to this complex issue? Readers will learn about the conflicts and potential solutions in this compelling volume
Member of
Cataloging source
DLC
Dewey number
338.4/361510973
Index
index present
LC call number
HD9665.4
LC item number
.S33 2018
Literary form
non fiction
Nature of contents
bibliography
http://library.link/vocab/relatedWorkOrContributorName
Schauer, Pete,
Series statement
Opposing viewpoints series
http://library.link/vocab/subjectName
  • Drugs
  • Prescription pricing
  • Pharmaceutical industry
  • Drugs
Target audience
adolescent
Label
Big pharma and drug pricing, Pete Schauer, book editor
Instantiates
Publication
Copyright
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Market exclusivity delays the availability of cheaper generic drugs
  • Zachary Brennan
  • Drug prices are high for legitimate reasons
  • Michael Rosenblatt, MD
  • Why don't insurance companies cover all prescription drugs?
  • Government-protected monopolies drive drug prices higher
  • Sydney Lupkin
  • Consumers are caught in the middle when the interests of drug companies and insurers conflict
  • Alison Kodjak
  • Employers should use their power to cut drug prices
  • Introduction
  • Robert Galvin, MD, Roger Longman
  • Lowering drug prices may mean switching medications
  • Alison Kodjak
  • "Medically necessary" drugs are increasing prices overall
  • Marcelle Arak and Sheila Tschinkel
  • Why are prescription drugs so expensive?
  • Truth behind the high costs of prescription drugs
  • Julie Appleby
  • Higher education plays an important role in the pharma industry
  • Annie Waldman
  • Patent laws keep drug prices high
  • Matthew Rimmer
  • Charles L. Hooper and David R. Henderson
  • Prescription demand is why Americans pay so much for drugs
  • Valerie Paris
  • Will we see legislative changes to the way drugs are priced?
  • Government reforms can address consumer concerns
  • Rachel Sachs
  • Big pharma has too much influence over politicians
  • Mike Ludwig
  • Transparency bills are the key to lowering drug prices
  • Michael Ollove --tIt's time to rein in exorbitant pharmaceutical prices
  • What are the ethics behind charging astronomical prices for prescription drugs?
  • Rafi Mohammed
  • Government doesn't deserve the blame for high drug prices
  • David Blumenthal, M.D. and David Squires
  • Pharma companies game the system to keep drugs expensive
  • Erin Fox
  • Ethics of pharmaceutical benefit management are blurry
  • Stephan L. Burton, Lauren Randel, Karen Titlow, and Ezekiel J. Emanuel
  • Americans spend more on prescriptions than most other countries
  • Steve Morgan and Jae Kennedy
  • Nothing stops drug companies from charging the highest market price
  • AARP
  • Encouraging competition is the answer to affordable pharmaceuticals
Dimensions
24 cm.
Edition
First edition.
Extent
208 pages
Isbn
9781534501768
Lccn
2017036789
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
System control number
  • ocn999672117
  • (OCoLC)999672117
  • 2390010
Label
Big pharma and drug pricing, Pete Schauer, book editor
Publication
Copyright
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Market exclusivity delays the availability of cheaper generic drugs
  • Zachary Brennan
  • Drug prices are high for legitimate reasons
  • Michael Rosenblatt, MD
  • Why don't insurance companies cover all prescription drugs?
  • Government-protected monopolies drive drug prices higher
  • Sydney Lupkin
  • Consumers are caught in the middle when the interests of drug companies and insurers conflict
  • Alison Kodjak
  • Employers should use their power to cut drug prices
  • Introduction
  • Robert Galvin, MD, Roger Longman
  • Lowering drug prices may mean switching medications
  • Alison Kodjak
  • "Medically necessary" drugs are increasing prices overall
  • Marcelle Arak and Sheila Tschinkel
  • Why are prescription drugs so expensive?
  • Truth behind the high costs of prescription drugs
  • Julie Appleby
  • Higher education plays an important role in the pharma industry
  • Annie Waldman
  • Patent laws keep drug prices high
  • Matthew Rimmer
  • Charles L. Hooper and David R. Henderson
  • Prescription demand is why Americans pay so much for drugs
  • Valerie Paris
  • Will we see legislative changes to the way drugs are priced?
  • Government reforms can address consumer concerns
  • Rachel Sachs
  • Big pharma has too much influence over politicians
  • Mike Ludwig
  • Transparency bills are the key to lowering drug prices
  • Michael Ollove --tIt's time to rein in exorbitant pharmaceutical prices
  • What are the ethics behind charging astronomical prices for prescription drugs?
  • Rafi Mohammed
  • Government doesn't deserve the blame for high drug prices
  • David Blumenthal, M.D. and David Squires
  • Pharma companies game the system to keep drugs expensive
  • Erin Fox
  • Ethics of pharmaceutical benefit management are blurry
  • Stephan L. Burton, Lauren Randel, Karen Titlow, and Ezekiel J. Emanuel
  • Americans spend more on prescriptions than most other countries
  • Steve Morgan and Jae Kennedy
  • Nothing stops drug companies from charging the highest market price
  • AARP
  • Encouraging competition is the answer to affordable pharmaceuticals
Dimensions
24 cm.
Edition
First edition.
Extent
208 pages
Isbn
9781534501768
Lccn
2017036789
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
System control number
  • ocn999672117
  • (OCoLC)999672117
  • 2390010

Library Locations

    • Main LibraryBorrow it
      310 North Tryon Street, Charlotte, NC, 28202, US
      35.2285213 -80.8421167
    • MatthewsBorrow it
      230 Matthews Station St., Matthews, NC, 28105, US
      35.1160092 -80.720516
    • South County RegionalBorrow it
      5801 Rea Road, Charlotte, NC, 28277, US
      35.086541 -80.8137402
Processing Feedback ...